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In this issue of JAMA Ophthalmology, an article by Ehrlich et al1 reports on the vision impairment 
findings of the World Health Organization’s Study on Global Aging and Adult Health (SAGE) study. 
The SAGE study is a longitudinal research project collecting nationally representative data on adults 
50 years and older and a smaller comparison sample of adults aged 18 to 49 years in China, Ghana, 
India, Mexico, the Russian Federation, and South Africa. The first wave of data collection occurred 
between 2007 and 2010.2 Because the study was supported by the US National Institute on Aging, 
Division of Behavioral and Social Research, national governments, and the World Health 
Organization, the microdata and weighted metadata are in the public domain. Ehrlich et al1 used 
these data to look at a series of nonophthalmological factors associated with presenting 
impairments in distance and near vision in each country; these included health, well-being, 
demographics, and the socioeconomic circumstances of participants and their households. There 
have been relatively few multicountry studies that combine measured vision loss and risk factors in 
older adults, and this study sheds an important light on these associations within low- and-middle-
income countries (which make up 84% of the global population). There are several reasons why this 
article is worthy of comment. 
The countries involved represent an important opportunity to address the sparseness of distance 
vision loss prevalence data from large sections of the world. For example, a large meta-analysis of 
population-based eye surveys called the Global Vision Database (GVD) reported that there had been 
only 5 high-quality studies on vision published in China between 1980 and 1999, with 33 such studies 
published between 2000 and 2014. The numbers of studies in the GVD for these periods number 0 
and 2, respectively, in Ghana, 5 and 13 in India, 0 and 1 in the Russian Federation, and 0 and 2 in 
Mexico. Nationally representative eye surveys are uncommon; only 44 of the 288 GVD study sources 
(15.8%), for example, were national in scope. 
Although the article1 does not report actual prevalence rates of distance vision impairment (defined 
as presenting visual acuity of <6/18, an approximate Snellen equivalent of less than 20/60, in the 
better eye) but rather reports the proportion of the sample affected, the completeness of the visual 
acuity data coverage (which exceeded 70% in most countries) and the relatively large sample sizes 
lend credence to the very substantial burden of distance vision impairment in these countries. This 
burden ranges from 10% in China and South Africa to 25% in the Russian Federation. Additionally, 
the near-vision loss burden is very large, ranging from 28% in Ghana to 43% in India. More recently, 
there have been some local studies in the Russian Federation,3 yet this work highlights the 
importance of improving understanding of vision loss burden in Central and Eastern Europe, as well 
as Latin America, where data sources are too scarce. 
It comes as no surprise that the age structure of populations makes a considerable difference to 
overall burden of distance vision loss and in all countries studied; in the article by Ehrlich et 
al,1 higher age and self-reported disability were significantly associated with distance vision 
impairment. Yet this study also showed that in most countries, poverty (measured in SAGE as a 
household wealth index), reduced physical functioning, comorbidities, cognitive impairment (as 
measured by memory function tested by verbal recall), and social isolation were also associated. 
Many of these factors of course are becoming increasingly common in aging populations. 
Country, regional, and global estimates of the prevalence of vision impairment are clearly of great 
importance, particularly in advocacy and for monitoring changes over time. The Vision Loss Expert 
Group’s Global Vision Database and the associated Vision Atlas project,4 which is made possible by a 
collaboration with the International Agency for Prevention of Blindness, go a long way toward 
making these data more accessible. The estimated burdens of vision impairment within each country 
by age and sex provided by these projects provide the rationale for scaling up eye care 
interventions.5,6 Yet as the period of the World Health Organization’s Global Action Plan (2014-2019) 
comes to an end and there is recognition that its target of a 25% reduction in avoidable blindness 
has not been met yet (owing largely to the aging of populations), perhaps the global eye care 
community should now set its sights on the inequity within countries and the factors that could be 
addressed to reduce these. 
Although there are limitations of the SAGE survey (such as not analyzing the ophthalmological 
causes of vision impairment; a relatively low participation rate of 70.5% and 72.9% in the Russian 
Federation for distance and near vision assessments, respectively; the involvement of proxy 
respondents; and a process of interviewing only a very small proportion of the population, which 
may miss high-risk groups7 and reduce population representativeness), this study1 has illustrated the 
heterogeneity in the factors that are associated with vision loss by country. Another important 
factor is the availability of health insurance among respondents of these surveys and whether this 
covered eye care. Yet these details was not reported by Ehrlich et al,1 although these data were 
collected by the SAGE survey. The proportion of the sample in receipt of an eye examination within 
the 2 years preceding the survey varied considerably between countries, ranging from 15% in Ghana 
to 53% in the Russian Federation. This is also of interest. 
Each country faces a unique set of environmental, social, and economic circumstances that are risk 
factors for late presentation of eye disease, and these are by no means limited to those of low- and 
middle-income countries. A major interest of this study1 is to provide information on in-country 
granularity of the associations that local socioeconomics and demographics have with vision 
impairment and receipt of eye care. The issue here is that in very large and diverse countries, such as 
China, the Russia Federation, and India, country-wide sampling may mask statistically significant 
differences between provinces, regions, and/or states. In other words, the intercountry 
heterogeneity of associations observed among countries may also exist within countries (eg, 
between Eastern and Western China), and this should be taken into account when planning future 
similar surveys. 
Detailed knowledge of these factors within countries would open up the opportunity to trial 
interventions more effectively not just by traditional eye care professionals but also in association 
with allied groups, such as educationalists, social care groups, specialists in diseases of elderly 
individuals (such as dementia and hearing loss), and economists. These efforts require in-country 
collaboration between governmental and nongovernmental organizations and patient and public 
participation. There are already many excellent examples of such programs in developing 
countries.8 Indeed, the ophthalmology community working among these other professionals offers 
the opportunity to raise awareness of the unacceptably high burden of vision loss and bring 
collaborative solutions tailor-made for individual countries and delivered in-country. 
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